{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "regularMarketPrice": 5.922, "exchange": "FRA", "shortName": "ADICET BIO INC. DL -,0001", "longName": "Adicet Bio, Inc.", "messageBoardId": "finmb_310073311", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": -2.6627247, "firstTradeDateMilliseconds": 1600408800000, "priceHint": 2, "regularMarketChange": -0.16200018, "regularMarketTime": 1683905766, "regularMarketDayHigh": 6.244, "regularMarketDayRange": "5.922 - 6.244", "regularMarketDayLow": 5.922, "regularMarketVolume": 1450, "regularMarketPreviousClose": 6.084, "bid": 5.856, "ask": 5.954, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 6.002, "averageDailyVolume3Month": 129, "averageDailyVolume10Day": 99, "fiftyTwoWeekLowChange": 1.2090001, "fiftyTwoWeekLowChangePercent": 0.25652453, "fiftyTwoWeekRange": "4.713 - 20.4", "fiftyTwoWeekHighChange": -14.478, "fiftyTwoWeekHighChangePercent": -0.7097059, "fiftyTwoWeekLow": 4.713, "fiftyTwoWeekHigh": 20.4, "earningsTimestamp": 1683663000, "earningsTimestampStart": 1691492400, "earningsTimestampEnd": 1692010800, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.54, "epsForward": -2.21, "epsCurrentYear": -2.0, "priceEpsCurrentYear": -2.961, "sharesOutstanding": 42957400, "bookValue": 6.806, "fiftyDayAverage": 6.0124, "fiftyDayAverageChange": -0.09040022, "fiftyDayAverageChangePercent": -0.015035629, "twoHundredDayAverage": 11.42235, "twoHundredDayAverageChange": -5.50035, "twoHundredDayAverageChangePercent": -0.48154277, "marketCap": 254393712, "forwardPE": -2.679638, "priceToBook": 0.87011456, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.4 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "symbol": "1IJA.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "200 Berkeley Street", "address2": "19th Floor", "city": "Boston", "state": "MA", "zip": "02116", "country": "United States", "phone": "650 503 9095", "website": "https://www.adicetbio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and chimeric adaptors to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also develops ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors; and ADI-925, a novel engineered CAd gamma delta T cell product candidate targeting tumor stress ligands. Adicet Bio, Inc. is based in Boston, Massachusetts.", "fullTimeEmployees": 132, "companyOfficers": [{"maxAge": 1, "name": "Mr. Chen  Schor BA, CPA, CPA, M.B.A., MBA", "age": 50, "title": "CEO, Pres & Director", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 899576, "fmt": "899.58k", "longFmt": "899,576"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 1843, "fmt": "1.84k", "longFmt": "1,843"}}, {"maxAge": 1, "name": "Dr. Aya  Jakobovits Ph.D.", "age": 67, "title": "Founder & Independent Director", "yearBorn": 1955, "fiscalYear": 2022, "totalPay": {"raw": 40000, "fmt": "40k", "longFmt": "40,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Blake  Aftab Ph.D.", "age": 41, "title": "Sr. VP & Chief Scientific Officer", "yearBorn": 1981, "fiscalYear": 2022, "totalPay": {"raw": 675039, "fmt": "675.04k", "longFmt": "675,039"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 22015, "fmt": "22.02k", "longFmt": "22,015"}}, {"maxAge": 1, "name": "Dr. Francesco  Galimi M.D., Ph.D.", "age": 54, "title": "Chief Medical Officer & Sr. VP", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": {"raw": 680365, "fmt": "680.37k", "longFmt": "680,365"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 266029, "fmt": "266.03k", "longFmt": "266,029"}}, {"maxAge": 1, "name": "Mr. Brian Nicholas Harvey", "age": 61, "title": "Chief Financial Officer", "yearBorn": 1961, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Donald  Healey Ph.D.", "age": 60, "title": "Chief Technology Officer", "yearBorn": 1962, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Amy  Locke", "title": "Head of HR", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Nancy L. Boman M.D., Ph.D.", "title": "Sr. VP & Chief Regulatory Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 4, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}